Whole-Body [<sup>18</sup>F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic Disease

Whole-Body [<sup>18</sup>F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic Disease

The 2-deoxy-d-[<sup>18</sup>F]fluoro-D-glucose (FDG) positron emission tomography/computed tomography (PET/CT) is widely utilized to assess the vascular and articular inflammatory burden of patients with a suspected diagnosis of rheumatic disease. We aimed to elucidate the impact of [<...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matthias Fröhlich, Sebastian Serfling, Takahiro Higuchi, Martin G. Pomper, Steven P. Rowe, Marc Schmalzing, Hans-Peter Tony, Michael Gernert, Patrick-Pascal Strunz, Jan Portegys, Eva-Christina Schwaneck, Ottar Gadeholt, Alexander Weich, Andreas K. Buck, Thorsten A. Bley, Konstanze V. Guggenberger, Rudolf A. Werner
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
giant cell arteritis
GCA
[<sup>18</sup>F]FDG PET/CT
vasculature
inflammation
polymyalgia rheumatica
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/b1962eacd28e46de946478204ed6988a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares